Study Some Virulence Factors of CO- agulase Positive Staphylococci and CO-agulase Negative Staphylococci Isolated from Different Parts of Human Body
Article Sidebar
Main Article Content
Abstract
This study included test production of some virulence factors that product from some species of Staphylococci: Co- agulase Positive Staphylococci (COPS) and Co-agulase Negative Staphylococci (CONS) that isolated from different parts of human body. (79%) of isolates was COPS while (21%) was CONS. All isolates showed production some virulence factors like (Protease, DNase, Lipase, Licithinase and Haemolysin) and the results were in COPS (64, 64, 55, 55 and 100)% respectively while all isolates of CONS were produced all this virulence factors except the licthinase . The results of all isolate were positive for oxidase test and negative for catalase test. From the results about (36.3%) of COPS produce white pigment and (63.6%) produced yellow pigment while all isolates of CONS was produced white pigment. Also the results showed that (86% and 71%) COPS isolates was produced haemolysine enzyme type (β and γ) while (14% and 29%) of CONS produced same enzyme type. Antibiotic susceptibility of all isolates were done,the results showed that all CONS isolates were Susceptible towards (Amikacin, Tobramycin, Tetraccline, Nitrofurantoin, Chloramphenicol and Clarithromycin) antibiotics but (33.3%) of CONS isolates were showed susceptible towards (Ampicillin, Amoxicillin, Cefdinir and Vancomycin) antibiotics. While in the COPS isolates showed low susceptibility rate towards (Vancomycin, Tetracycline Amikacin and Tobramycin) antibiotics and in different percentage (81.8, 54.5 and 90.9)% respectively while (42.8,36.3, 9, 18.1, and 45.5)% were susceptible to (Ampicillin, Cfidor, Pencillin, Amoxicillin, Ticarcillin-clavulanic acid, Tobramycin, Cephalothin, Erythromycin, Chloramphenicol and Clarithromycin) respectively.
In conclusion, all isolates which have high resistance to antibiotics have low susceptible to same antibiotics
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1. Fung-Tomc, J.C., Clark, J., Minassian, B., Pucci, M., Tsai,Y., Gradelski, E., Lamb, L., Medina, I., Huczko, E., Kolek, B., Chaniewski, S., Ferraro,C.l., Washo, T., and Bonner, D. P. 2002. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin resistant and susceptible Staphylococci. Antimicrob. Agents Chemother. 46(4): 971-976.
2. Gill, S.R., Fouts, D.E., Archer, G.L., Mongodin, E.F., De Boy, R.T., Ravel,J., Paulsen, I.T., Kolonay, J.F., Brinkac, L., Beanan, M., Dodson,R.J., Daugherty, S.C., Madupu, R., Angiuoli, S.V., Durkin, A.S., Haft, D.H., Vamathevan, J., Khouri, H., Utterback, T., Lee, C., Dimitrov, G., Jiang, L., Qin, H., Weidman, J., Tran, K., Kang, K., Hance, I.R., Nelson, K.E. and Fraser, C.M. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin resistant Staphylococcus epidermidis strain. J. Bacteriol. 187(7): 2426- 2438.
3. Gordon RJ, Lowy FD. 2008. Pathogenesis of methicillinresistant Staphylococcus aureus infection. Clin Infect Dis. 46:S350-S359.
4. Archer GL. 1998. Staphylococcus aureus: A well-armed pathogen. Clin Infect Dis. 26:1179-1181.
5- Engleberg NC, DiRita V, Dermody TS.2006. Schaechter’s Mechanisms of Microbial disease. Fourth edition ,Chapter 11:147-155
6-Cheng AG, McAdow M, Kim HK, Bae T, Missiakas D, Schneewind O. 2010. Contribution of Coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog , 6:e1001036
7-McAdow M, Missiakas DM, Schneewind O. 2012. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. J Innate Immun, 4:141-148
8. Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Azeredo J. 2005.Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother. 56:331-336.
9. Frank KL, Reichert EJ, Piper KE, Patel R. 2007. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother. 51:888-895.
10- Elufisan, T. O.,Oyedara, O. O. and Oyelade, B. 2011.Updates on microbial resistance to drugs . Afr. J. Microbiol. Res. 6(23): 4833-4844.
11- Alfred, E.B. 2005. Bensons microbiological applications in laboratory manual in general microbiology. 9th ed. McGraw – Hill. Companies. U.S.A.
12 - Zunino, P. Piccini, C. and Legnanifajard, C.1999. Groth, Cllular differention and virulence factor expression by proteus mirabilis in vitro and vivo. J. Med .Microbiol.48:34-527.
13- Cruickshank, R.; Duguid, J.P.; Marmion, B.P. and Swain, R.H.A. (1975).Vol.2 The Practical of medical microbiology 12th ed. Churchill livingstone.
14- Brooks, G. F.; Caroll, K. C., and Morse, S. A. 2007. Staphylococcus (Jawetz). Melnick and delberg’s, Medical Microbiology. 24th edition. The McGraw-Hill. New York.
15- Baird-Parker, A.C.1962. An improved diagnostic and selective medium for isolating coagulase positive staphylococci. J. Appl. Bacteriol. 25:12-19.
16- MacFaddin, J. F. 2000. Biochemical tests for identification of medical bacteria. 3rd ed. Lipicott Williams and Wilkins USA.
17- Harley, J. p. and Prescott, L. M. 2002. Laboratory Exercises in Microbiology. 5th ed. McGraw Hill.
18- Bauer AW, Kirby WM, Sherris JC, Turck M. 1966. Antibiotic susceptibility testing by a standardized single disk method. Am J. Clin Pathol. 45: 493-96.
19- AL- Rawi, K .M. and Mohammad, M.K. 2000. Designed and analysis of agricultural experiments. Dar alkutob, Mosul, Iraq:73-77.
20- Pancholi V. 2001. Staphylococcal Extracellular/ Surface Enzymatic activity. In: Staphylococcus aureus Infection and Disease (Honeyman AL, Friedman H, Bendinellim, eds.). Kluwer Academic/ Plenum Publishers, New York, USA,p.137-153.
21- Benson. 2001. Microbiological Applications, Laboratory Manual in General Microbiology. 8th.ed. The McGraw-Hill Companies, Inc., New York.
22- Holt, J.G.; N.R. Krieg; P.H.A. Sneath; J.T. Staley; and S.T. Williams. 1994. Bergy,s Manual of Determinative Bacteriology. 9th.ed. Williams & Wilkins, USA. P.532-551.
23- Yokoyama A, Miki W. 1955. Composition and presumed biosynthetic pathway of carotenoids in the astaxanthin-producing bacterium Agrobacterium aurantiacum. FEMS Microbiol. Lett.128:139-144
24- Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, Fierer J, and Nizet V. 2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. T. The Journal of Experimental Medicine. 202(2), 209-215.
25- Ryan KJ, Ray CG. 2004. Sherris Medical Microbiology: An Introduction to Infectious Diseases. 4th edn. McGraw Hill Publishers.
26- Mekhael R, Yousif SY. 2009. The Role of Red Pigment Produced by Serratia marcescens as Antibacterial and Plasmid Curing Agent. J. Duhok Univ.12(1):268-274.
27- Nakashima T, Kurachi M, Kato Y, Yamaguchi K, Oda T.2005. Characterization of bacterium isolated from the sediment at coastal area of omura bay in Japan and several biological activities of pigment produced by this isolate. Microbiol. Immunol. 49(5):407–415.
28- Joshi VK, Attri D, Bala A, Bhishan S. 2003. Microbial pigments. Ind. J.Biotechnol. 2:362-369.
29- Jongkon, S., Sudarat, S., Metta, O. and Supang, P.2012. Lipase, Protease and Biofilm as the virulence factor in Staphlococci isolated from acne lesions. BioScience Trends,6(4):160-164.
30- Fathi, N.N. 2007. A study on some Virulence Factors of Coagulase Negative Staphylococci isolated from skin infection in Sullaimaniya hospitals. M.Sc. Thesis. College of Science. University of Baghdad.
31- Rollof J, Hedström SA, Nilsson-Ehle P.1987. Lipolytic activity of Staphylococcus aureus strains from disseminated and localized infections. Acta Pathol Microbiol Immunol Scand . 95(2):109–113.
32- Rooijakkers, S. H., van Wamel, W. J., Ruyken, M., van Kessel, K. P. & van Strijp, J. A. 2005. Anti-opsonic properties of staphylokinase. Microbes Infect. 7:476–484.
33- Ryding U., Renneberg J., Rollof J., Christensson B.1992. Antibody response to Staphylococcus S.aureus whole cell, lipase and staphylolysin in patients with S. aureus infections. FEMS Microbiol. Immunol. 4 :105.
34- Dinges MM, Orwin PM, and Schlievert PM. 2000. Exotoxins of Staphylococcus aureus. Clinical Microbiology Reviews.13(1):16-34.
35- LinY-C and Peterson ML.2010. New insights into the prevention of staphylococcal infections and toxic shock syndrome. Expert Review of Clinical Pharmacology 3(6): 753-767.
36- Adesida, S.A.; O.A. Abioye; B.S. Bamiro; B.I.C. Brai1; S.I. Smith; K.O. Amisu; D.U. Ehichioya; F.T. Ogunsola; and A.O. Coker. 2007. Associated Risk Factors and Pulsed Field Gel Electrophoresis of Nasal Isolates of Staphylococcus aureus from Medical Students in a Tertiary Hospital in Lagos, Nigeria. BJID.11(1):63-69.
37- Votava, M.; Skalka, B. and Sediva, J.1990. Slime production, hemolysis and proteolysis in coagulase-negative staphylococci isolated in hemoculture from humans. Cesk Epidemiol. Mikrobiol. Imunol. 39(5): 288-293.
38- Hassan S, Jamal S, Kamal M. 2011. Occurrence of multidrug resistant and ESBL producing E. coli causing urinary tract infections, J. of Basic and Applied Sciences.7(1):39- 43.
39- Sahm D, Critchley I, Kelly J, Karlowsky D, Mayfield C, Thornsberry Y, Kahn J. 2001.Evaluation of current activities of fluoroquinolones against gram negative bacilli centralized in vitro testing and electronic surveillance. Antimicrob. Agents Chemotherapy. 45(1):267-274.
40- Nada Khazal Kadhim Hindi1, Shaimaa O. Hasson and Shatha Khazal Kadhim Hindi.2013. Bacteriological Study of Urinary Tract Infections with Antibiotics Susceptibility to Bacterial Isolates among Honeymoon Women in Al Qassim Hospital, Babylon Province, Iraq British Biotechnology Journal ,3(3): 332-340.
41- Von Eiff, C.; R.R. Reinert; M. Kresken; J. Brauers; D. Hafner; and G. Peters. 2000. Nationwide German Multicenter Study on Prevalence of Antibiotic Resistance in Staphylococcal Bloodstream Isolates and Comparative. In Vitro Activities of Quinupristin - Dalfopristin. J. Clin. Microbiol. 38(8): 2819-2823.
42- Calderón-Jaimes, E.; L.E. Monteros; and R. Avila-Beltrán. 2002. Epidemiology of drug resistance: The case of Staphylococcus aureus and coagulase-negative staphylococci infections. Salud pública de méxico.44(2):108-112.
43- Gill, S.R.; D.E. Fouts; G.L. Archer; E.F. Mongodin; R.T. DeBoy; J. Ravel; I.T. Paulsen; J.F. Kolonay; L. Brinkac; M. Beanan; R.J. Dodson; S.C. Daugherty; R. Madupu; S.V. Angiuoli; A.S. Durkin; D.H. Haft. J. Vamathevan; H. Khouri; T. Utterback; C. Lee; G. Dimitrov; L. Jiang; H. Qin; J. Weidman; K. Tran; K. Kang; I.R. Hance; K.E. Nelson; and C.M. Fraser. 2005. Insights on Evolution of Virulence and Resistance from the Complete Genome Analysis of an Early Methicillin-Resistant Staphylococcus aureus Strain and a Biofilm-Producing Methicillin-Resistant Staphylococcus epidermidis Strain. J. Bacteriol. 187(7):2426-2438.
44- Oliveira, D.C., de Lencastre, H., 2011. Methicillin-resistance in Staphylococcus aureus is not affectedby the overexpression in Trans of the mecA gene repressor: a surprising observation. PLoS One 6, e23287. 324.
45-Jaquelyn G.B. and Laura J.B. 2013. Microbiology. 8th ed. John welly & sons, INC. P: 324-335.
46- Gupta K. 2003. Addressing antibiotic resistance. Dis Mon.49:99-110.
47- Mittal P, Deborah A. 2005. Urinary Tract Infections in Pregnancy. Clin Perinatol. 32:749–764.
48- Biadglegne F, Abera B.2009. Antimicrobial resistance of bacterial isolates from urinary tract infections at Felge Hiwot Referral Hospital Ethiopia. Ethiop. J. Health Dev.23(3):236-238.